Stock PHO PHOTOCURE ASA
Add to a list
To use this feature you must be a member
Log inSign up

News Photocure ASA

Equities

PHO

NO0010000045

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-26 am EDT 		5-day change 1st Jan Change
55.4 NOK +1.84% Intraday chart for Photocure ASA +1.09% -17.80%
Apr. 08 Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France CI
Mar. 28 Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Photocure ASA - Share option grant
AQ
Photocure ASA - European Association of Urology 2024 congress features new data on modern technology use in bladder cancer care
AQ
Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France
CI
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
AQ
Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference
AQ
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
AQ
Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
CI
Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO
AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO
AQ
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
AQ
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
AQ
Transcript : Photocure ASA, Q4 2023 Earnings Call, Feb 21, 2024
Photocure ASA: Results for the fourth quarter of 2023
AQ
Photocure ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results
AQ
Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024
AQ
Photocure ASA - Share option grant
AQ
Photocure : Partner Asieris to present unpublished clinical trial and real-world data on Hexvix in China at ASCO GU 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHO Stock
  4. News Photocure ASA